MedTrace Logo

Gastrointestinal Tolerance Study of a New Infant Formula

NCT01681355 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2013-01-09

No results posted yet for this study

Summary

This study is initiated to investigate the gastrointestinal tolerance of a new infant formula in healthy, term, Asian infants.

Conditions

  • Healthy Infants

Interventions

OTHER

Infant Formula

Standard cow's milk based infant formula with added prebiotic oligosaccharides, and a modified fat blend and protein composition

Sponsors & Collaborators

  • Danone Asia Pacific Holdings Pte, Ltd.

    lead INDUSTRY

Principal Investigators

  • Jan van der Mooren, PhD · Danone Global Research & Innovation Center

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
17 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Indonesia
  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01681355 on ClinicalTrials.gov